Skip to main content

Events

Sabre's MCP Server Hits Scale with Nearly 80 Airline, Agency Clients

Image
Sabre's MCP Server Hits Scale with Nearly 80 Airline, Agency Clients

Southlake, Texas – September 20, 2026 -- Sabre Corporation (NASDAQ: SABR) has moved nearly 80 customers into piloting or full production on its Model Context Protocol (MCP) server, a year after launching the technology that lets AI agents book, sell and service travel directly on the company's data and inventory.

Sabre launched its MCP server in September 2025, a full year ahead of rivals now announcing similar agentic AI plans

The server acts as a connective layer allowing AI agents to transact directly against Sabre's travel data and inventory. Clients using the technology include Virgin Australia, Flight Centre, and Internova — spanning its Global Travel Collection, Nexion, ALTOUR and Travel Leaders Network brands — with the company citing real bookings and cost savings already realized.

IBM Study: 60% of Workers Fear AI Is Eroding Critical Thinking Skills

Image
IBM Study: 60% of Workers Fear AI Is Eroding Critical Thinking Skills

Armonk, N.Y. – September 20, 2026 -- Seventy-one percent of Chief Human Resource Officers say the ability to supervise, validate and override AI outputs is now the most essential workforce skill, yet only 29% of employees rank judgment as important, according to a new global study from the IBM Institute for Business Value.

Envision Energy Energises Morocco's First Large-Scale Battery Storage at OCP Site

Image
Envision Energy Energises Morocco's First Large-Scale Battery Storage at OCP Site

Benguerir, Morocco – September 20, 2026 -- Envision Energy has energised Morocco's first large-scale lithium iron phosphate battery storage system, a 25 MW / 125 MWh unit installed at OCP Green Energy's Benguerir mining site.

System cuts peak-hour electricity costs by roughly 25% at industrial site

The battery storage system, supplied and commissioned by Envision Energy under a contract signed in late 2025, shifts surplus daytime solar power to peak consumption hours. The company integrated the BESS with the site's solar generation, grid conditions and industrial load profile, and the system is now undergoing testing before entering commercial operation.

Reap Launches Managed Fraud Service Sentry for Card Programs

Image
Reap Launches Managed Fraud Service Sentry for Card Programs

Hong Kong – September 20, 2026 -- Reap has launched Sentry, a managed fraud and risk service that eliminates the need for card-issuing clients to build in-house fraud teams or license separate monitoring tools.

Global card fraud losses hit $33.41 billion in 2024, Nilson Report data shows

Payment card fraud losses worldwide totalled USD 33.41 billion in 2024, tied to global card volume of USD 51.920 trillion, according to The Nilson Report's January 2026 figures. Reap cites the millisecond nature of authorisation decisions as the reason fraud must be intercepted at the point of transaction rather than remediated afterward.

Abbisko's Lavengratinib Shows 2.4cm/Year Growth Gain in Achondroplasia Trial

Image
Abbisko's Lavengratinib Shows 2.4cm/Year Growth Gain in Achondroplasia Trial

Shanghai – September 20, 2026 -- Abbisko Therapeutics Co., Ltd. (HKEX: 02256.HK) reported that its oral FGFR2/3 inhibitor lavengratinib achieved a mean increase of 2.4 cm/year in annualized height velocity among children with achondroplasia in the lowest-dose cohort of a Phase II trial, with a 100% responder rate.

Seven children in the first dose cohort completed six months of treatment with no serious adverse events

All seven participants aged 6 to 12 in cohort 1 of the ABSK061-202 study received lavengratinib at 0.064 mg/kg once daily for 27 weeks. Responders were defined as achieving at least a 25% improvement in annualized height velocity from baseline, a threshold every participant in the cohort met.

LG Display Launches World's First 720Hz Gaming OLED Panel

Image
LG Display Launches World's First 720Hz Gaming OLED Panel

Seoul – September 20, 2026 -- LG Display has begun mass production of a 24.5-inch Gaming OLED panel with a 720Hz refresh rate, the highest ever achieved in a gaming OLED display, alongside a 0.02ms response time.

LG Display sets new refresh-rate benchmark for esports monitors

The panel is the first OLED display built specifically for the esports segment, where 24-inch class monitors dominate because they let players view the full screen at a glance. To hit 720Hz at FHD (1920x1080) resolution, LG Display developed a proprietary driving algorithm and an integrated design spanning panel construction to the driving system, reducing motion blur and ghosting in fast-paced genres such as first-person shooter and racing games.

Convera, JustLogin Embed Cross-Border Payroll in 16 Currencies

Image
Convera, JustLogin Embed Cross-Border Payroll in 16 Currencies

Seattle – September 20, 2026 -- Convera and JustLogin have partnered to embed regulated cross-border payroll and business payment capabilities directly into JustLogin's HR platform, enabling companies to initiate payments in up to 16 currencies across Singapore and Southeast Asia.

Partnership targets $105 billion regional B2B payments opportunity

Southeast Asia's B2B payments market was valued at approximately USD 44.5 billion in 2024 and is projected to exceed USD 105 billion by 2033, according to figures cited by the companies. The integration positions JustLogin's HR platform to capture a share of that growth by letting customers manage payroll disbursement without leaving their existing workflow.

Velocys Launches AlphaCore 800, Doubling Fischer-Tropsch Reactor Capacity

Image
Velocys Launches AlphaCore 800, Doubling Fischer-Tropsch Reactor Capacity

Houston and Oxford – September 20, 2026 -- Velocys has released the AlphaCore 800, its highest-capacity microchannel Fischer-Tropsch reactor to date, capable of producing up to 800 barrels per day, or 30,000 tonnes per year, from a single unit.

New reactor doubles capacity of predecessor model

AlphaCore 800 doubles the throughput of the AlphaCore 400 and extends Velocys' reactor family range from roughly 50 to 800 barrels per day per unit, or 2 to 30 kt/a. The reactor targets larger sustainable aviation fuel (SAF) and e-fuels projects, including plants aiming for approximately 100,000 tonnes per year and above.

Antengene Doses First Patient in Phase III Trial of ADC ATG-022

Image
Antengene Doses First Patient in Phase III Trial of ADC ATG-022

Shanghai – September 20, 2026 -- Antengene Corporation Limited (SEHK: 6996.HK) has dosed the first patient in China in its pivotal Phase III CLINCH-3 study evaluating ATG-022, a CLDN18.2 antibody-drug conjugate, as monotherapy for CLDN18.2-positive advanced gastric or gastroesophageal junction adenocarcinoma.

Breakthrough Therapy Designation accelerated the trial's launch

China's National Medical Products Administration granted ATG-022 Breakthrough Therapy Designation, which the company says streamlined regulatory communications and enabled the rapid start of CLINCH-3. The randomized, controlled, open-label multicenter study is initiated in China and planned for expansion into a multi-regional clinical trial, with Professor Lin Shen of Peking University Cancer Hospital serving as principal investigator. The study compares ATG-022 against treatment of investigator's choice, targeting a future marketing approval application.

UN Forum: CEOs, Leaders Push Grid, Policy Fixes to Speed Energy Transition

Image
UN Forum: CEOs, Leaders Push Grid, Policy Fixes to Speed Energy Transition

New York – September 20, 2026 -- More than 100 CEOs, heads of state and UN leaders concluded the 2026 UN Private Sector Forum in New York calling for faster public-private cooperation to unlock clean-energy investment, citing grid bottlenecks, regulatory uncertainty and financing gaps as the main barriers to deployment at scale.

UN Secretary-General urges companies to deploy capital and purchasing power

Hosted by the UN Global Compact on behalf of Secretary-General António Guterres, the invitation-only session pressed business leaders to close the gap between existing climate commitments and the pace of change needed to keep the 1.5°C target within reach. Guterres told participants that companies possess the capital, technology, supply chains and consumer base to "supercharge the renewables revolution" through direct investment in clean power and energy efficiency, and by using purchasing power to build markets for clean technologies.

01F Group Invests in Indonesia's DANA to Expand Digital Finance Access

Image
01F Group Invests in Indonesia's DANA to Expand Digital Finance Access

Singapore – September 20, 2026 -- 01F Group has made an investment in DANA, Indonesia's leading digital e-wallet and financial services platform, through its growth-stage fintech private equity arm, 01Fintech. The deal deepens 01F Group's exposure to Southeast Asia's fintech sector as Indonesia's digital payments market is projected to approach USD 1 trillion by 2030.

DANA's platform reaches millions of users across Tier 2 to Tier 4 regions

DANA operates an integrated digital financial ecosystem serving consumers, merchants and financial institutions, with particular penetration among micro, small and medium enterprises (MSMEs) outside Indonesia's major metropolitan centers. Founded in 2018, the platform combines digital payments, QRIS transactions, money transfers and AI-powered financial tools.

Specialised Therapeutics Expands Incyte Deal for Opzelura in Australia

Image
Specialised Therapeutics Expands Incyte Deal for Opzelura in Australia

Singapore – September 20, 2026 -- Specialised Therapeutics (ST) has expanded its partnership with Incyte Biosciences International to commercialise, distribute, and register ruxolitinib cream, marketed as Opzelura, in Australia.

ST gains rights to market Opzelura for vitiligo and atopic dermatitis in Australia

Under the expanded agreement, Incyte will continue to develop and manufacture ruxolitinib cream, a topical Janus kinase (JAK) inhibitor, while ST takes on regulatory submissions, medical affairs, marketing, and distribution across the Australian market. The drug is approved in the U.S. and European Union for treating non-segmental vitiligo and mild-to-moderate atopic dermatitis in patients who do not respond adequately to standard topical therapies.

Field Medical's PFA Catheter Hits 94.2% Vein Durability in 12-Month Trial

Image
Field Medical's PFA Catheter Hits 94.2% Vein Durability in 12-Month Trial

Atlanta and Carlsbad, Calif. – September 20, 2026 -- Field Medical, Inc. reported 12-month outcomes from its first-in-human Field PULSE trial showing 94.2% per-vein durability for pulmonary vein isolation using an optimized waveform, with results published in JACC: Clinical Electrophysiology and presented as a Late-Breaking Clinical Trial at HRX Live 2026.

Subsecond ablation cuts median procedure time to 13 minutes

The trial recorded a 13-minute median elapsed pulmonary vein isolation (PVI) ablation time, with a fastest case completed in 7.7 minutes. Field Medical's high-voltage focal pulsed field ablation (PFA) architecture, delivered through its FieldForce PFA System, applies energy in under 200 milliseconds per point, reducing the need for prolonged catheter stability during atrial procedures.

Wearable Nerve Stimulator Shows Signal in Reducing AF Recurrence Post-Ablation

Image
Wearable Nerve Stimulator Shows Signal in Reducing AF Recurrence Post-Ablation

Atlanta and Los Angeles – September 20, 2026 -- StimCardio Medical reported that patients treated with non-invasive median nerve stimulation (MNS) after atrial fibrillation (AF) ablation showed 90.0% freedom from atrial arrhythmias at six months, compared with 80.8% for those receiving sham treatment, though the difference did not reach statistical significance. The randomized, double-blind, sham-controlled NeuroPulse pilot study was presented as late-breaking clinical science at HRX Live 2026 and simultaneously published in the peer-reviewed journal Heart Rhythm.

Post-blanking analysis finds statistically significant drop in arrhythmia events

In a sensitivity analysis conducted after the 60-day blanking period, patients receiving MNS recorded 12 recurrent atrial arrhythmia events versus 28 in the sham group, a statistically significant reduction (p=0.025). No MNS- or device-related serious adverse events were reported across the trial.

Des Moines Insurer Ranks Priority Coverage Order for Small Firms

Image
Des Moines Insurer Ranks Priority Coverage Order for Small Firms

Urbandale, Iowa – September 20, 2026 -- Small businesses in the Des Moines metro should secure general liability insurance first, followed by property coverage and workers' compensation, according to insights from Ben Buenzow, an insurance expert at Buenzow Insurance Group, featured in a HelloNation article.

General liability insurance forms the first line of financial defense for small operators

The coverage protects companies against claims of bodily injury or property damage stemming from business operations, addressing risks from customers, vendors, or visitors. Legal costs and settlements tied to such claims can be significant enough to threaten a small firm's cash flow without this protection in place.

Xi Pushes Advanced Manufacturing as China's Robot Output Jumps 34.6%

Beijing – September 20, 2026 -- Chinese President Xi Jinping has ordered sustained expansion of advanced manufacturing, calling for smart, green and integrated industrial upgrading to strengthen supply-chain self-sufficiency, according to instructions conveyed at a national conference on advanced manufacturing in Beijing reported by Xinhua News Agency.

Xi, who also chairs the Central Military Commission, said industrial chains must become more self-supporting and risk-resilient while pursuing higher-quality development and greater security. Premier Li Qiang told the conference that developing advanced manufacturing must be treated as a major strategic task.

S2S China Names 10 Biotech Finalists for Westlake Pitch Event

Image
S2S China Names 10 Biotech Finalists for Westlake Pitch Event

Shanghai – – September 20, 2026 -- Ten biotech startup teams have been selected as finalists for the inaugural S2S China Symposium, narrowed from roughly 20 semifinalists who competed to pitch global venture investors at Westlake University on October 15.

RA Capital and Qiming Venture Partners co-host China chapter of Science2Startup

S2S China is the China chapter of Science2Startup, an invitation-only program founded in 2018 by F-Prime, SV Health and Atlas Venture that connects academic therapeutics researchers with biotech investors. RA Capital Management, Osage University Partners and 5AM Ventures have since joined the network. The China edition is co-hosted by RA Capital Management and Qiming Venture Partners.

Siemba Automates IDOR Testing Across Full API Collections

Image
Siemba Automates IDOR Testing Across Full API Collections

Atlanta – September 20, 2026 -- Siemba has launched automated testing for insecure direct object reference (IDOR) flaws, cutting the time to scan a 200-endpoint API collection to under an hour, a task the company says has typically taken human testers days or weeks.

IDOR ranks first among OWASP's API Security Top 10 risks

IDOR, classified by OWASP as broken object level authorization, occurs when an endpoint fails to verify that a caller-supplied identifier belongs to them, allowing a single changed number in a request to expose another user's data. Siemba's Chief Security Officer Sandhya Prashanth said the flaw "drives a huge share of real-world breaches" and requires little more than systematic testing across every endpoint to detect.

Accro Bioscience Doses First Patient in AC-101 Phase IIb UC Trial

New York and Suzhou, China – September 20, 2026 -- Accro Bioscience Inc. has dosed its first patient in a Phase IIb trial testing AC-101, a selective RIPK2 inhibitor, in patients with moderate-to-severe ulcerative colitis (UC).

Trial spans roughly 50 clinical sites with three treatment arms

The multicenter, double-blind, placebo-controlled study is designed across approximately 50 clinical sites and includes two AC-101 dose cohorts plus a placebo control arm. The primary endpoint is clinical remission rate at Week 12, with exploratory endpoints covering histologic remission and long-term maintenance of clinical and histologic remission.

Beijing Unveils Green Economy Blue Book, Global Standards Initiative at 2026 Forum

Beijing – September 20, 2026 -- Nearly 400 domestic and international delegates gathered at the Beijing Municipal Administrative Center (BMC) on September 17 as the Beijing Green Development Forum 2026 opened, unveiling a new blue book on the capital's green economy and a standards-led transition initiative backed by more than 20 institutions.

Hosted by Asia Data Group and organized by ADG Expo Group, the forum carried the theme "Green Empowerment, Low-Carbon Symbiosis" and drew support from Global Honorary Partner Huaxia Bank and strategic partner Beijing Energy Holding Co., Ltd. International bodies including the World Green Design Organization, C40 Cities Climate Leadership Group, and the Center for China & Globalization backed the event.